Abstract: The invention discloses a therapeutic topical composition, includes an extract of Galenia Africana having anti-microbial and anti-oxidant action. The composition includes rooibos and/or an extract from rooibos tea plant. The composition is adapted for regenerating skin, stimulating cyto-keratin production, treating human external fungal infections and/or conditions, human skin bacterial conditions, psoriasis, psoriasis plaque, dandruff, acne, bacterial acnes, eczema, athletes' foot, nappy rash, baby rash and/or lesions and/or being used for anti-septic wound treatment, and/or treating Propionibacterium acnes and/or staphylococcus epidermidis.
Abstract: The present invention discloses a cancer treatment method which includes the step of treating a patient having cancer with an extract from Galenia Africana L. plant. The extract may include pinocembrin and/or 2?,4? dihydroxychalcone and/or 7-hydroxyflavanone. The cancer may be breast cancer or melanoma. The composition may be solubilized with MPG and/or Suganate.
Abstract: The invention discloses a fungicide preparation, which includes an extract and/or isolate of Galena africana; and mono-propylene glycol as a solvent and/or SAS as surfactant and/or polysuganate as a mild anionic surfactant. The extract and/or isolate may be KB05. The preparation may include mono-propylene glycol as a solvent for KBO5 and if kept anhydrous, the KBO5 remains stable in the mixture. The mixture may act as a low hazard stable source of KBO5 that can be mixed with the desired anionic surfactant and water to make formulations suitable for various applications. The preparation may include SAS as surfactant for producing stable solutions/micro emulsions of KBO5 in combination with propylene glycol.
Type:
Grant
Filed:
November 28, 2016
Date of Patent:
September 15, 2020
Assignee:
BIOPHARM NZ LIMITED
Inventors:
Michael-John Joseph Barry, Bernard Cecil Kimble